127 related articles for article (PubMed ID: 21986524)
1. High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis.
Ahn J; Lee H; Chung CH; Ha T
Biochem Biophys Res Commun; 2011 Nov; 414(4):664-9. PubMed ID: 21986524
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion.
Tian GP; Chen WJ; He PP; Tang SL; Zhao GJ; Lv YC; Ouyang XP; Yin K; Wang PP; Cheng H; Chen Y; Huang SL; Fu Y; Zhang DW; Yin WD; Tang CK
Biochimie; 2012 Dec; 94(12):2749-55. PubMed ID: 22963823
[TBL] [Abstract][Full Text] [Related]
3. Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet.
Ahn J; Lee H; Jung CH; Ha T
Mol Nutr Food Res; 2012 Nov; 56(11):1665-74. PubMed ID: 22968990
[TBL] [Abstract][Full Text] [Related]
4. The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice.
Tian GP; Tang YY; He PP; Lv YC; Ouyang XP; Zhao GJ; Tang SL; Wu JF; Wang JL; Peng J; Zhang M; Li Y; Cayabyab FS; Zheng XL; Zhang DW; Yin WD; Tang CK
Biochem Biophys Res Commun; 2014 Jan; 443(2):428-34. PubMed ID: 24309104
[TBL] [Abstract][Full Text] [Related]
5. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice.
Hoekstra M; van der Sluis RJ; Kuiper J; Van Berkel TJ
J Nutr Biochem; 2012 Jun; 23(6):622-8. PubMed ID: 21764575
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
8. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
9. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS
Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
11. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
Estep M; Armistead D; Hossain N; Elarainy H; Goodman Z; Baranova A; Chandhoke V; Younossi ZM
Aliment Pharmacol Ther; 2010 Aug; 32(3):487-97. PubMed ID: 20497147
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
14. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease.
Kim MH; Kang KS; Lee YS
Br J Nutr; 2010 Nov; 104(9):1333-42. PubMed ID: 20687969
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.
Zhang B; Li H; Li D; Sun H; Li M; Hu H
Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698
[TBL] [Abstract][Full Text] [Related]
17. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
18. A novel function of microRNA 130a-3p in hepatic insulin sensitivity and liver steatosis.
Xiao F; Yu J; Liu B; Guo Y; Li K; Deng J; Zhang J; Wang C; Chen S; Du Y; Lu Y; Xiao Y; Zhang Z; Guo F
Diabetes; 2014 Aug; 63(8):2631-42. PubMed ID: 24677715
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues.
Kim YJ; Hwang SH; Cho HH; Shin KK; Bae YC; Jung JS
J Cell Physiol; 2012 Jan; 227(1):183-93. PubMed ID: 21381024
[TBL] [Abstract][Full Text] [Related]
20. IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs.
Wang JM; Qiu Y; Yang Z; Kim H; Qian Q; Sun Q; Zhang C; Yin L; Fang D; Back SH; Kaufman RJ; Yang L; Zhang K
Sci Signal; 2018 May; 11(530):. PubMed ID: 29764990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
